Literature DB >> 22001397

EGFR is dispensable for c-Met-mediated proliferation and survival activities in mouse adult liver oval cells.

A Martínez-Palacián1, G Del Castillo2, B Herrera3, M Fernández4, C Roncero5, I Fabregat6, A Sánchez7.   

Abstract

Liver progenitor cells rise as potential critical players in hepatic regeneration but also carcinogenesis. It is therefore mandatory to define the signals controlling their activation and expansion. Recently, by using a novel in vitro model of oval cell lines expressing a mutant tyrosine kinase-inactive form of c-Met we demonstrated that autocrine c-Met signalling plays an essential role in promoting oval cell survival. Here, we investigated the significance of the epidermal growth factor receptor (EGFR) signalling in oval cell proliferation and survival, as well as a potential functional crosstalk between the c-Met and the EGFR pathways. We found an autocrine activation of the EGFR-triggered pathway in Met(flx/flx) and Met(-/-) oval cells as judged by constitutive expression of the EGFR ligands, transforming growth factor-alpha (TGF-α) and heparin-binding EGF like growth factor (HB-EGF), and activation of EGFR. On the other hand, treatment with AG1478, a specific inhibitor of EGFR, effectively blocked endogenous and EGF-induced proliferation, while increased serum withdrawal and transforming growth factor-beta (TGF-β)-induced apoptosis. These results suggest that constitutively activated EGFR might promote oval cell proliferation and survival. We found that hepatocyte growth factor (HGF) does not transactivate EGFR nor EGF transactivates c-Met. Furthermore, treatment with AG1478 or EGFR gene silencing did not interfere with HGF-mediated activation of target signals, such as protein kinase B (AKT/PKB), and extracellular signal-regulated kinases 1/2 (ERK 1/2), nor did it have any effect on HGF-induced proliferative and antiapoptotic activities in Met(flx/flx) cells, showing that HGF does not require EGFR activation to mediate such responses. EGF induced proliferation and survival equally in Met(flx/flx) and Met(-/-) oval cells, proving that EGFR signalling does not depend on c-Met tyrosine kinase activity. Together, our results provide strong evidence that in normal, untransformed oval cells, c-Met and EGFR represent critical molecular players to control proliferation and survival that function independent of one another.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001397     DOI: 10.1016/j.cellsig.2011.09.031

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

1.  A common p53 mutation (R175H) activates c-Met receptor tyrosine kinase to enhance tumor cell invasion.

Authors:  Katharine D Grugan; Maria E Vega; Gabrielle S Wong; J Alan Diehl; Adam J Bass; Kwok K Wong; Hiroshi Nakagawa; Anil K Rustgi
Journal:  Cancer Biol Ther       Date:  2013-06-18       Impact factor: 4.742

2.  Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader
Journal:  World J Exp Med       Date:  2012-04-20

3.  EGFR and c-Met Cross Talk in Glioblastoma and Its Regulation by Human Cord Blood Stem Cells.

Authors:  Kiran Kumar Velpula; Venkata Ramesh Dasari; Swapna Asuthkar; Bharathi Gorantla; Andrew J Tsung
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

4.  High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients.

Authors:  Israel Cañadas; Alvaro Taus; Iria González; Xavier Villanueva; Javier Gimeno; Lara Pijuan; Manuel Dómine; Albert Sánchez-Font; Ivan Vollmer; Silvia Menéndez; Oriol Arpí; Sergi Mojal; Federico Rojo; Ana Rovira; Joan Albanell; Edurne Arriola
Journal:  Oncotarget       Date:  2014-07-30

Review 5.  EGFR Signaling in Liver Diseases.

Authors:  Karin Komposch; Maria Sibilia
Journal:  Int J Mol Sci       Date:  2015-12-29       Impact factor: 5.923

6.  Oncological transformation in vitro of hepatic progenitor cell lines isolated from adult mice.

Authors:  Rocío Olivera-Salazar; Mariano García-Arranz; Aránzazu Sánchez; Susana Olmedillas-López; Luz Vega-Clemente; Luis Javier Serrano; Blanca Herrera; Damián García-Olmo
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

7.  Mouse hepatic oval cells require Met-dependent PI3K to impair TGF-β-induced oxidative stress and apoptosis.

Authors:  Adoración Martínez-Palacián; Gaelle del Castillo; Amileth Suárez-Causado; María García-Álvaro; Diego de Morena-Frutos; Margarita Fernández; Cesáreo Roncero; Isabel Fabregat; Blanca Herrera; Aránzazu Sánchez
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

8.  Yi Guan Jian decoction may enhance hepatic differentiation of bone marrow‑derived mesenchymal stem cells via SDF‑1 in vitro.

Authors:  Lin-Lin Fu; Bing-Yao Pang; Ying Zhu; Ling Wang; Ai-Jing Leng; Hai-Long Chen
Journal:  Mol Med Rep       Date:  2017-06-29       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.